![](https://external.xx.fbcdn.net/safe_image.php?d=AQDX827oaXttLX5o&w=470&h=246&url=http%3A%2F%2Frheumnow.com%2Fsites%2Fall%2Fthemes%2Frheumnow%2Fimages%2Fstickylogo.jpg&cfs=1&upscale=1&ext=png2jpg)
rheumnow.com
Unlike the anti-TNFs in RA, where combination with MTX is superior to either agent alone, Tocilizumab (TCZ; anti-IL6) is superior to MTX, and the combination was not statistically better than TCZ alone. This is a boon for patients who tolerate MTX poorly.
However, the SURPRISE Study suggests that combination TCZ+MTX works faster and better in achieving RA remission and in prevention of joint damage (Xray progression), especially in those with more aggressive disease.